Teva Canada Limited v. Pfizer Canada Inc., 2014 FC 634 (Venlafaxine*)

Justice Zinn - 2014-06-30

Read full decision. Automatically generated summary:

In the Reasons for Judgment (2014 FC 248), the parties were instructed to attempt to reach agreement on the quantum of damages and costs.  The parties have agreed, based on the various findings made in these proceedings, that the total damages accruing during the Relevant Period (January 10, 2006 to August 1, 2007), is $92,228,000.00, as set out in the following table.

Decision relates to:


Canadian Intellectual Property